Novo Nordisk Case Study

Novo Nordisk helps some patients through haemostasis management. Haemostasis is the human body’s physical response to bleeding and hemorrhage (rupture of a blood vessel). It stops bleeding by blocking the vascular breach. Haemostasis has 3 steps: primary haemostasis, secondary haemostasis, and fibrinolysis. Primary haemostasis consists of vasoconstriction (constriction of blood vessels) and the formation of a platelet plug, made by platelets and fibrinogen, that blocks the breach. Secondary haemostasis stops any further bleeding by a series of chemical reactions by plasma components. Fibrinolysis is the process that dissolves the blood clot once the blood vessel has been fixed.
Novo Nordisk treats patients with hemophilia A and B as well as